Clarivate (NYSE:CLVT) Announces Earnings Results, Beats Estimates By $0.04 EPS

Clarivate (NYSE:CLVT) posted its quarterly earnings results on Wednesday. The company reported $0.18 EPS for the quarter, topping analysts’ consensus estimates of $0.14 by $0.04, FiscalAI reports. The business had revenue of $585.50 million during the quarter, compared to the consensus estimate of $569.50 million. Clarivate had a positive return on equity of 8.76% and a negative net margin of 5.61%.The company’s revenue for the quarter was down 1.4% compared to the same quarter last year. During the same period last year, the firm earned $0.14 earnings per share. Clarivate updated its FY 2026 guidance to 0.700-0.800 EPS.

Here are the key takeaways from Clarivate’s conference call:

• Q1 results showed improving profitability with $586M revenue, adjusted EBITDA of $241M (41% margin, up ~200 bps YoY) and adjusted EPS of $0.18, alongside modest organic ACV growth of 1.6% and a company subscription mix around 89%.
• Management says the Value Creation Plan and AI investments are driving product adoption and efficiency—customers report 30%–60% reductions in repetitive work and 2x–4x throughput gains on some library workflows, plus new AI-enabled products and partnerships (e.g., Anthropic integration).
• Clarivate reaffirmed full-year guidance but expects overall revenue to fall roughly $100M–$130M (midpoint to $2.36B) due to planned disposals and is actively pursuing a possible sale of the Life Sciences & Healthcare business, which could require guidance revisions if completed.
• Cash generation and deleveraging remain priorities: Q1 free cash flow was $79M, the company retired ~$143M of debt during the quarter, repurchased bonds and shares, and reiterated a plan to generate ~ $400M FCF for the year and materially reduce net leverage toward ~2.5x over the next few years.

Clarivate Stock Performance

Shares of NYSE:CLVT traded down $0.09 during trading hours on Friday, hitting $2.79. The stock had a trading volume of 7,423,327 shares, compared to its average volume of 6,876,528. The stock’s fifty day simple moving average is $2.47 and its 200 day simple moving average is $2.95. Clarivate has a 1-year low of $1.66 and a 1-year high of $4.77. The firm has a market capitalization of $1.79 billion, a price-to-earnings ratio of -13.26 and a beta of 1.39. The company has a debt-to-equity ratio of 0.89, a quick ratio of 0.84 and a current ratio of 0.84.

Analyst Ratings Changes

CLVT has been the topic of a number of recent research reports. Barclays cut their target price on shares of Clarivate from $4.00 to $2.40 and set an “underweight” rating on the stock in a report on Wednesday, February 25th. Royal Bank Of Canada cut their target price on shares of Clarivate from $5.00 to $3.00 and set a “sector perform” rating on the stock in a report on Wednesday, February 25th. Weiss Ratings reissued a “sell (e+)” rating on shares of Clarivate in a report on Friday, March 27th. Citigroup cut their target price on shares of Clarivate from $4.25 to $2.80 and set a “neutral” rating on the stock in a report on Wednesday, March 4th. Finally, Wall Street Zen cut shares of Clarivate from a “buy” rating to a “hold” rating in a report on Saturday, February 28th. Five research analysts have rated the stock with a Hold rating and three have given a Sell rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Reduce” and a consensus price target of $3.22.

Institutional Investors Weigh In On Clarivate

Several large investors have recently made changes to their positions in CLVT. Royal Bank of Canada increased its stake in shares of Clarivate by 96.2% in the first quarter. Royal Bank of Canada now owns 63,630 shares of the company’s stock valued at $250,000 after purchasing an additional 31,197 shares during the period. AQR Capital Management LLC increased its stake in shares of Clarivate by 37.0% during the first quarter. AQR Capital Management LLC now owns 451,872 shares of the company’s stock valued at $1,749,000 after acquiring an additional 122,099 shares during the period. Millennium Management LLC increased its stake in shares of Clarivate by 1,420.4% during the first quarter. Millennium Management LLC now owns 1,188,978 shares of the company’s stock valued at $4,673,000 after acquiring an additional 1,110,774 shares during the period. Goldman Sachs Group Inc. increased its stake in shares of Clarivate by 15.5% during the first quarter. Goldman Sachs Group Inc. now owns 616,250 shares of the company’s stock valued at $2,422,000 after acquiring an additional 82,768 shares during the period. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its stake in shares of Clarivate by 13.1% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,243,683 shares of the company’s stock valued at $4,888,000 after acquiring an additional 144,462 shares during the period. Institutional investors and hedge funds own 85.72% of the company’s stock.

Clarivate Company Profile

Clarivate plc is a global information and analytics company that provides insights and workflow solutions to accelerate the pace of innovation. The company delivers proprietary data, analytics, and expertise to support research and development in the life sciences, intellectual property management, academic institutions, government agencies, and corporations. Its core offerings include citation and patent databases, drug pipeline analytics, trademark research tools, regulatory compliance solutions, and market intelligence platforms.

Originally part of Thomson Reuters’ Intellectual Property & Science division, Clarivate was established as an independent entity in 2016 following a spin-off transaction.